Kinetics and computational analysis of cholinesterase inhibition by REVERC3, a bisdemethoxycurcumin-rich extract: Relevance to the treatment of Alzheimer’s disease

Kinetics and computational analysis of cholinesterase inhibition by REVERC3, a bisdemethoxycurcumin-rich extract: Relevance to the treatment of Alzheimer’s disease

Objectives: Cholinesterase inhibition is a common strategy to treat Alzheimer’s disease. In this study, we have investigated the cholinesterase inhibitory effects of a first-of-its-kind turmeric extract (REVERC3) having enriched content of bisdemethoxycurcumin as major active curcuminoid. Methods :...

Full description

Bibliographic Details
Main Authors:	Sudeep HV, Amritha Raj, Gouthamchandra K, Chandrappa S, Shyamprasad K
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-11-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/2050312120973499

Similar Items

Efficacy of a Standardized Turmeric Extract Comprised of 70% Bisdemothoxy-Curcumin (REVERC3) Against LPS-Induced Inflammation in RAW264.7 Cells and Carrageenan-Induced Paw Edema
by: Gouthamchandra K, et al.
Published: (2021-03-01)

In vitro gastrointestinal digestion of a bisdemethoxycurcumin-rich Curcuma longa extract and its oral bioavailability in rats
by: Venkataramana Heggar Sudeep, et al.
Published: (2021-04-01)

Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer’s Disease
by: Edward J. Okello, et al.
Published: (2020-04-01)

Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up‐regulating SIRT1
by: Yan Xu, et al.
Published: (2020-07-01)

Acute and sub-chronic toxicity evaluation of a standardized green coffee bean extract (CGA-7™) in Wistar albino rats
by: Venkatakrishna K, et al.
Published: (2021-02-01)

Cholinesterases in Alzheimer's disease
by: Navaratnam, Dasakumar Selveraj
Published: (1990)

Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination
by: Qiu C, et al.
Published: (2020-03-01)

CHOLINESTERASE INHIBITORS IN THE TREATMENT OF DEMENTIA ALZHEIMER’S
by: Prameidya Primaniar S
Published: (2013-03-01)

Cholinesterases in senile dementia of Alzheimer-type
by: Atack, John Richard
Published: (1984)

Leveraging host metabolism for bisdemethoxycurcumin production in Pseudomonas putida
by: Matthew R. Incha, et al.
Published: (2020-06-01)

Phytochemical Analysis and Cholinesterase Inhibitory and Antioxidant Activities of Enhydra fluctuans Relevant in the Management of Alzheimer’s Disease
by: Simin Shabnam Lopa, et al.
Published: (2021-01-01)

Determination of cholinesterase inhibition potential of rose extract
by: Esra Şentürk, et al.
Published: (2018-10-01)

Chlorogenic acid complex (CGA7), standardized extract from green coffee beans exerts anticancer effects against cultured human colon cancer HCT-116 cells
by: K. Gouthamchandra, et al.
Published: (2017-09-01)

A novel kinetic cholinesterase-inhibition based method for quantification of biperiden in pharmaceutical preparations
by: Đurić Vladan R., et al.
Published: (2020-01-01)

Comparative Studies on the Antioxidant Profiles of Curcumin and Bisdemethoxycurcumin in Erythrocytes and Broiler Chickens
by: Jingfei Zhang, et al.
Published: (2019-11-01)

Phytochemical composition of Caesalpinia crista extract as potential source for inhibiting cholinesterase and β-amyloid aggregation: Significance to Alzheimer's disease
by: Kolambe Rajappa Chethana, et al.
Published: (2018-01-01)

Effects of cholinesterase inhibition on brain function
by: Bentley, P. I.
Published: (2011)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
by: Wattmo Carina, et al.
Published: (2012-11-01)

Green-synthesized gold nanocubes functionalized with bisdemethoxycurcumin analog as an ideal anticancer candidate
by: Devi Rajagopal Aruna, et al.
Published: (2014-02-01)

Impact of Antrodia cinnamomea, bisdemethoxycurcumin, demethoxycurcumin, and curcumin on P-glycoprotein expression and function
by: Yu-Ning Teng, et al.
Published: (2013)

Relevance of Plasma Cholinesterase to Clinical Findings in Acute Organophosphorous Poisoning
by: Devanur R.M.M. Prasad, et al.
Published: (2013-03-01)

CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer's disease.
by: Pei-Hsuan Weng, et al.
Published: (2013-01-01)

Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
by: Weiam Hussein, et al.
Published: (2018-08-01)

Alzheimer's disease and Type 2 diabetes mellitus: the cholinesterase connection?
by: Siva Prasad Akula, et al.
Published: (2006-11-01)

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
by: Martina Zimmermann, et al.
Published: (2005-06-01)

Cholinesterase inhibition in chicks treated with manganese chloride
by: M. Al-Zubaidy, et al.
Published: (2019-01-01)

Bisdemethoxycurcumin Induces Apoptosis in Activated Hepatic Stellate Cells via Cannabinoid Receptor 2
by: Phil Jun Lee, et al.
Published: (2015-01-01)

In vitro antioxidant and cholinesterase inhibitory activities of Elatostema papillosum leaves and correlation with their phytochemical profiles: a study relevant to the treatment of Alzheimer’s disease
by: A. S. M. Ali Reza, et al.
Published: (2018-04-01)

Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans
by: L.I. Zimerman, et al.
Published: (2010-02-01)

Isothiocyanates: cholinesterase inhibiting, antioxidant, and anti-inflammatory activity
by: Franko Burčul, et al.
Published: (2018-01-01)

The mechanism by which oximes reactivate cholinesterases inhibited by organophosphates
by: Bhavaraju, Manikanthan
Published: (2013)

The Mechanism of Bisdemethoxycurcumin Enhances Conventional Antibiotics against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Shu Wang, et al.
Published: (2020-10-01)

The cytotoxic effect of curumin, demethoxycurcumin and bisdemethoxycurcumin purified from Turmeric powder on leukemic cell lines
by: Songyot Anuchapreeda, et al.
Published: (2015-03-01)

Bisdemethoxycurcumin re-expresses of ER-α through ILK inhibition is regulated by a pathway involving Twist andYB-1 in TNBC cells
by: Chun-Chen Huang, et al.
Published: (2014)

Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells
by: Jin-Hong Xu, et al.
Published: (2015-01-01)

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease
by: Hafsa Amat-ur-Rasool, et al.
Published: (2021-02-01)

Studies on pyroglutamyl carboxyl peptidase enzymes and cholinesterase inhibitors : implications for Alzheimer's disease
by: Connelly, Stephen
Published: (2006)

Evaluating the Therapeutic Response of Acetyl-cholinesterase Inhibitor in Alzheimer''s Disease
by: Yuan-Han Yang, et al.
Published: (2011)

The effect of cholinesterase inhibitors on sleep in the patients with Alzheimer’s disease: an observational prospective study
by: Osman Korucu, et al.
Published: (2018-01-01)

Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity
by: Magdalena Markowicz-Piasecka, et al.
Published: (2017-01-01)